Details for New Drug Application (NDA): 061187
✉ Email this page to a colleague
NDA 061187 describes CHLOROPTIC S.O.P., which is a drug marketed by Allergan and is included in one NDA. Additional details are available on the CHLOROPTIC S.O.P. profile page.
The generic ingredient in CHLOROPTIC S.O.P. is chloramphenicol. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol profile page.
The generic ingredient in CHLOROPTIC S.O.P. is chloramphenicol. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol profile page.
Summary for 061187
| Tradename: | CHLOROPTIC S.O.P. |
| Applicant: | Allergan |
| Ingredient: | chloramphenicol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061187
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
